Conclusion
Our retrospective study results demonstrate that sugammadex is not associated with an increase in postoperative bleeding events, had less PONV, did not affect the organ rejection rate, and did not affect hospital length of stay. We provide incremental evidence sugammadex can be considered as an alternative to antagonize neuromuscular blockade following orthotopic liver transplantation.
Author Contribution :
  1. Hong Liang: Drafting and revision of the article, Data collection.
  2. Ryan Chadha: Concept and study design, critical revision of article
  3. J. Ross Renew: Concept and study design, critical revision of article. Approval of article.
  4. Launia J White: Data analysis and interpretation and statistics.